Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of combination therapy of rosuvastatin and fenofibrate versus
rosuvastatin monotherapy in mixed dyslipidemia patients: A randomized, multi-center,
double-blind, phase 3 study